Economic impact of a more extensive use of FENO testing on the Italian population with asthma

BACKGROUND: Asthma is a common chronic inflammatory airway affecting over 260 million people worldwide, and characterized, in the large majority of cases, by the so-called “type 2 inflammation”. Fractional exhaled nitric oxide (FE(NO)) testing is noninvasive point-of-care tool to assess type 2 infla...

Descripción completa

Detalles Bibliográficos
Autores principales: Rognoni, Carla, Milano, Carlo, Heffler, Enrico, Bonini, Matteo, Brussino, Luisa, Carpagnano, Giovanna Elisiana, Ricciardolo, Fabio Luigi Massimo, Costa, Francesco, Armeni, Patrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236694/
https://www.ncbi.nlm.nih.gov/pubmed/37268938
http://dx.doi.org/10.1186/s12931-023-02437-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236694/
https://www.ncbi.nlm.nih.gov/pubmed/37268938
http://dx.doi.org/10.1186/s12931-023-02437-y

Ejemplares similares